-
COMPARATIVE EFFECTIVENESS OF CONSOLIDATION DURVALUMAB VERSUS OSIMERTINIB IN PATIENTS WITH UNRESECTABLE, STAGE III, EGFR-MUTATED NON-SMALL-CELL LUNG CANCER: A SYSTEMATIC REVIEW
Mar 18, 2026, 21:38 PM -
ANTIHYPERTENSIVE TREATMENT PATTERNS BEFORE AND DURING PREGNANCY AMONG WOMEN WITH CHRONIC HYPERTENSION: A REAL-WORLD EHR STUDY
Mar 18, 2026, 21:38 PM -
COMPARATIVE RISK OF SUICIDAL IDEATION AND SELF-HARM AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH BREXPIPRAZOLE VERSUS OTHER ORAL ATYPICAL ANTIPSYCHOTICS: A PROPENSITY SCORE-MATCHED COHORT ANALYSIS
Mar 18, 2026, 21:38 PM -
ASSESSING ACCESS TO INNOVATIVE ORPHAN MEDICINES IN LATIN AMERICA: A CROSS-COUNTRY VALUE AND ACCESS ANALYSIS
Mar 18, 2026, 21:38 PM -
PATIENT-CENTRIC PATHWAYS: SURVEYING TREATMENT ACCESS AND SUPPORT FOR RARE DISEASES, INCLUDING RARE CANCERS, IN EUROPE
Mar 18, 2026, 21:38 PM -
SPENDING ON GENE THERAPIES FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
Mar 18, 2026, 21:38 PM -
WHY CURRENT INTERTEMPORAL DISCOUNTING METHODS ARE WRONG, HOW THEY DISTORT HEALTH TECHNOLOGY ASSESSMENT, COST-EFFECTIVENESS ANALYSIS AND ESTIMATES OF THE VALUE OF A LIFE-YEAR AT FULL HEALTH, AND HOW TO FIX THE PROBLEM
Mar 18, 2026, 21:38 PM -
COMPARISON OF BENEFIT DESIGN FOR DIABETES MEDICATIONS BETWEEN CONVENTIONAL MEDICARE ADVANTAGE PLANS AND CHRONIC CONDITION SPECIAL NEEDS PLANS
Mar 18, 2026, 21:38 PM -
THE BLOCKBUSTER BATTLE IN OBESITY: DO NEWER SEMAGLUTIDE DOSES CLOSE THE GAP? A TIME-COURSE MODEL-BASED NMA
Mar 18, 2026, 21:38 PM -
TRENDS IN INPATIENT COSTS AND DRIVERS OF HIGH-COST HOSPITALIZATIONS AMONG INDIVIDUALS WITH OPIOID USE DISORDER
Mar 18, 2026, 21:38 PM -
THE DYNAMICS OF EXACERBATION-RELATED HEALTH-STATE TRANSITIONS IN UNCONTROLLED ASTHMA: A MARKOV-BASED MULTI-CRITERIA ANALYSIS
Mar 18, 2026, 21:38 PM -
COST-BENEFIT ANALYSIS OF CLOSED-SYSTEM AND OPEN-SYSTEM INFUSION OF HUMAN SERUM ALBUMIN IN ICU PATIENTS
Mar 18, 2026, 21:38 PM -
REAL-WORLD SAFETY AND OUTCOMES OF BISPECIFIC ANTIBODIES IN OLDER ADULTS
Mar 18, 2026, 21:38 PM -
PREDICTORS OF INITIATING MEDICATIONS FOR OPIOID USE DISORDER IN THE EMERGENCY DEPARTMENT: A RETROSPECTIVE COHORT STUDY
Mar 18, 2026, 21:38 PM -
ASSOCIATION BETWEEN DIET QUALITY AND CARDIOVASCULAR DISEASE MORTALITY IN CANCER SURVIVORS IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
REAL-WORLD DATA LARGE LANGUAGE MODEL ASSISTIVE SQL CODING SYSTEM
Mar 18, 2026, 21:38 PM -
ASSESSING THE IMPACT OF INCLUSION OF PATIENTS WITH MISSING EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG) PERFORMANCE STATUS IN REAL-WORLD OUTCOMES OF THIRD-LINE OR LATER (3L+) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
Mar 18, 2026, 21:38 PM -
ASSOCIATION OF SOCIAL DETERMINANTS OF HEALTH WITH RARE CANCER BURDEN IN THE UNITED STATES: A MEPS-BASED ANALYSIS
Mar 18, 2026, 21:38 PM -
COST-SAVINGS ASSOCIATED WITH VENETOCLAX-OBINUTUZUMAB VERSUS COVALENT BRUTON’S TYROSINE KINASE INHIBITOR IN FRONTLINE CHRONIC LYMPHOCYTIC LEUKEMIA: A REAL-WORLD STUDY
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF SEMAGLUTIDE FOR METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS UNDER MEDICARE DRUG PRICE NEGOTIATIONS
Mar 18, 2026, 21:38 PM
